CollPlant Biotechnologies Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.043 million compared to USD 0.109 million a year ago. Net loss was USD 4.38 million compared to USD 4.38 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.4 a year ago.
For the nine months, sales was USD 10.66 million compared to USD 0.241 million a year ago. Net loss was USD 2.33 million compared to USD 12.52 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 1.14 a year ago.